The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CEA response at four weeks as an early predictor for outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab-based chemotherapy: A STEP-analysis in the JACCRO CC-05/06 trials.
 
Yu Sunakawa
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Merck Serono (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Xuemin Fang
Consulting or Advisory Role - AnGes; Shionogi; Taiho Pharmaceutical
 
Masahito Kotaka
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hiroaki Tanioka
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Satoshi Tani
No Relationships to Disclose
 
Tatsuro Yamaguchi
No Relationships to Disclose
 
Takanori Watanabe
No Relationships to Disclose
 
Toshiki Masuishi
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Masahiro Tsuda
No Relationships to Disclose
 
Tatsuya Okuno
No Relationships to Disclose
 
Takao Tamura
No Relationships to Disclose
 
Kaoru Furushima
No Relationships to Disclose
 
Hidekazu Kuramochi
No Relationships to Disclose
 
Junichi Koike
No Relationships to Disclose
 
Yutaka Yonemura
No Relationships to Disclose
 
Hisateru Yasui
No Relationships to Disclose
 
Masahiro Takeuchi
No Relationships to Disclose
 
Masashi Fujii
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization; Taiho Pharmaceutical
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Merck Serono (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)